Menter AM, Draelos Z, Heim J, Gogineni R, Griffiths CE. Efficacy and safety by body weight decile in patients treated with tildrakizumab 100 mg for 28 weeks: Pooled data analysis of reSURFACE 1 and reSURFACE 2. J of Skin [Internet]. 2023 Mar. 13 [cited 2024 Jul. 4];7(2):s136. Available from: https://jofskin.org/33014/index.php/skin/article/view/2007